Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

mAbs

Showing results (971-980 of 1,834) with videos related to

Pageof 184
Sort By:
Mabs|January 6, 2017
Guiding bispecific monovalent antibody formation through proteolysis of IgG1 single-chainNazzareno Dimasi, Ryan Fleming, Kris F Sachsenmeier, et al.
Mabs|December 9, 2016
An elaborate landscape of the human antibody repertoire against enterovirus 71 infection is revealed by phage display screening and deep sequencingZhe Chen, Xianwen Ren, Jian Yang, et al.
Mabs|December 15, 2016
Antibodies to watch in 2017Janice M Reichert
Mabs|December 21, 2016
Trimeric gp120-specific bovine monoclonal antibodies require cysteine and aromatic residues in CDRH3 for high affinity binding to HIV EnvBehnaz Heydarchi, Rob J Center, Jonathan Bebbington, et al.
Mabs|October 1, 2016
Corrigendum
Mabs|October 13, 2022
A competitive binding-mass spectrometry strategy for high-throughput evaluation of potential critical quality attributes of therapeutic monoclonal antibodiesZhengqi Zhang, Yuetian Yan, Shunhai Wang, et al.
Mabs|October 5, 2022
The impact of forced degradation conditions on mAb dimer formation and subsequent influence on aggregation propensityMichael J Knight, Léontine Floret, Nisha Patel, et al.
Mabs|February 9, 2021
One size does not fit all: navigating the multi-dimensional space to optimize T-cell engaging protein therapeuticsWei Chen, Fan Yang, Carole Wang, et al.
Mabs|February 18, 2021
Off-target binding of an anti-amyloid beta monoclonal antibody to platelet factor 4 causes acute and chronic toxicity in cynomolgus monkeysLise I Loberg, Meha Chhaya, Alexander Ibraghimov, et al.
Mabs|February 19, 2021
Coming together at the hinges: Therapeutic prospects of IgG3Thach H Chu, Edward F Patz, Margaret E Ackerman
Pageof 184

Showing results (971-980 of 1,834) with videos related to

Sort By:
Pageof 184
Mabs|January 6, 2017
Guiding bispecific monovalent antibody formation through proteolysis of IgG1 single-chainNazzareno Dimasi, Ryan Fleming, Kris F Sachsenmeier, et al.
Mabs|December 9, 2016
An elaborate landscape of the human antibody repertoire against enterovirus 71 infection is revealed by phage display screening and deep sequencingZhe Chen, Xianwen Ren, Jian Yang, et al.
Mabs|December 15, 2016
Antibodies to watch in 2017Janice M Reichert
Mabs|December 21, 2016
Trimeric gp120-specific bovine monoclonal antibodies require cysteine and aromatic residues in CDRH3 for high affinity binding to HIV EnvBehnaz Heydarchi, Rob J Center, Jonathan Bebbington, et al.
Mabs|October 1, 2016
Corrigendum
Mabs|October 13, 2022
A competitive binding-mass spectrometry strategy for high-throughput evaluation of potential critical quality attributes of therapeutic monoclonal antibodiesZhengqi Zhang, Yuetian Yan, Shunhai Wang, et al.
Mabs|October 5, 2022
The impact of forced degradation conditions on mAb dimer formation and subsequent influence on aggregation propensityMichael J Knight, Léontine Floret, Nisha Patel, et al.
Mabs|February 9, 2021
One size does not fit all: navigating the multi-dimensional space to optimize T-cell engaging protein therapeuticsWei Chen, Fan Yang, Carole Wang, et al.
Mabs|February 18, 2021
Off-target binding of an anti-amyloid beta monoclonal antibody to platelet factor 4 causes acute and chronic toxicity in cynomolgus monkeysLise I Loberg, Meha Chhaya, Alexander Ibraghimov, et al.
Mabs|February 19, 2021
Coming together at the hinges: Therapeutic prospects of IgG3Thach H Chu, Edward F Patz, Margaret E Ackerman
Pageof 184